AzTrials
AzTrials

Molar HypomineralizationNCT07756216

Pulpotomy in Hypominerlized Permanent Molars.

A study testing Step wise pulpotomy in people with Molar Hypomineralization, run by King Abdullah University Hospital at 1 site in Jordan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The first permanent molars in children can sometimes develop a condition called molar-incisor hypomineralization (MIH), which affects the strength and quality of the tooth structure. Read more about this study

Who is it for?
Ages 6 to 14 yearsHealthy volunteers can take part
Conditions the study is for
Molar Hypomineralization
What is being tested?
Step wise pulpotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteJordan
Study dates
21 Dec 2025to Jul 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • • The patient age <14 years old
  • Non -contributory medical history
  • Molar tooth affected with MIH as per EAPD diagnostic criteria (17).
  • Deep caries extending>= 2/3 of dentine or exposing the pulp on the radiograph
  • The tooth should give positive response to cold sensibility testing
  • Clinical diagnosis of reversible/irreversible pulpitis based on the symptoms and results of cold testing.
  • The tooth is restorable, probing pocket depth and mobility are within normal limits
  • No signs of pulpal necrosis including sinus tract or swelling

Who cannot join

  • • Medically compromised patient.
  • Non-restorable tooth.
  • Signs of pulpal necrosis including sinus tract or swelling.
  • Uncooperative children who could not be treated under local anesthesia.
  • No enough bleeding after the pulpotomy procedure.
  • Inability to achieve hemostasis within 8 min after the pulpotomy.

Trial locations and contacts

1 site in 1 country.

Jordan1 site
  • Jordan university of science and Technology

    Irbid, 3030

Other trials in Jordan

About this study

Official title: Outcome of Pulpotomy in MIH Affected Teeth With Carious Pulp Exposure: A Prospective Clinical Study.

The first permanent molars in children can sometimes develop a condition called molar-incisor hypomineralization (MIH), which affects the strength and quality of the tooth structure. These teeth are more prone to breakdown and tooth decay, which may lead to inflammation of the dental pulp (the living tissue inside the tooth).

This study aims to evaluate the effectiveness of vital pulp therapy, a treatment designed to preserve the health of the pulp and maintain the tooth's function. The goal is to save the pulp tissue and reduce the need for more complex treatments such as root canal therapy.

Read the detailed description

Molar-incisor hypomineralization (MIH) is a developmental enamel defect affecting permanent first molars and incisors. Affected molars are more vulnerable to post-eruptive enamel breakdown, dental caries progression, and subsequent pulpal inflammation. When caries progresses to involve the pulp, preserving pulp vitality through vital pulp therapy (VPT) may provide an alternative to root canal treatment, particularly in young patients.

Although partial and full pulpotomy have shown favorable outcomes in young permanent teeth with deep caries and pulp exposure, limited evidence is available regarding their effectiveness in teeth affected by MIH. MIH-affected teeth may have altered pulpal characteristics, including increased vascularity, inflammatory response, and sensitivity, which may influence the response to vital pulp therapy.

This prospective clinical study aims to evaluate the clinical and radiographic outcomes of a stepwise pulpotomy approach in young permanent first molars affected by MIH with deep caries and pulp exposure. Eligible teeth will initially receive partial pulpotomy. If adequate hemostasis cannot be achieved following partial pulpotomy, treatment will be converted to full pulpotomy. A calcium silicate-based material will be used for pulp capping, followed by definitive restoration.

Clinical and patient-reported outcomes will be assessed, including postoperative pain, the need for emergency intervention, and signs or symptoms of treatment failure. Radiographic evaluation will be performed at 6 and 12 months using periapical radiographs, with additional imaging when indicated, to assess the presence of periapical or furcal pathology, root changes, and overall treatment success.

The study will also investigate potential factors associated with treatment outcomes, including patient and tooth characteristics, MIH severity, pulpotomy type performed (partial or full pulpotomy), and pulpal inflammatory markers such as matrix metalloproteinase-9 (MMP-9). The findings will contribute to understanding the effectiveness and predictability of vital pulp therapy for MIH-affected permanent molars with carious pulp exposure.

Being tested
Step wise pulpotomy
Medical subject headings
Molar Hypomineralization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Step wise pulpotomyProcedure or surgery

    The stepwise vital pulp therapy approach include : partial pulpotomy will be performed initially, and if adequate hemostasis cannot be achieved, the procedure will be converted to full pulpotomy to the level of the root canal orifices.

Study groups in NCT07756216
Study groupRoleWhat they receive
MIH-Affected Permanent Molars Receiving Stepwise Pulpotomy TreatmentExperimentalMIH affected molars will receive a stepwise vital pulp therapy approach. Partial pulpotomy will be performed initially, and if adequate hemostasis cannot be achieved, the procedure will be converted to full pulpotomy. A calcium silicate-based pulp capping material and definitive restoration will be placed following the pulpotomy procedure. Participants will be followed clinically and radiographically for treatment outcomes.
Receives: Procedure: Step wise pulpotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success of pulpotomy

    Clinical and radiographic success will be assessed based on the presence or absence of signs and symptoms of treatment failure at follow-up visits. Clinical success will be defined as the absence of spontaneous pain, tenderness to percussion or palpation, swelling, sinus tract, abnormal mobility, or other clinical signs of pulpal or periapical disease. For teeth undergoing partial pulpotomy, continued positive response to pulp sensibility testing will also be considered a criterion for clinical success. Radiographic success will be defined as the absence of new pathological findings, including periapical or furcal radiolucency, root resorption, or other radiographic evidence of treatment failure on follow-up imaging.

    Measured: 6 and 12 months after treatment

Secondary outcomes (1)
  1. Postoperative pain after pulpotomy

    Postoperative pain will be assessed using an 11-point Numeric Rating Scale (NRS), where 0 represents no pain and 10 represents the worst possible pain. Participants or their parents/guardians will report pain intensity following the pulpotomy procedure. The pain scores will be used to evaluate the postoperative pain response after vital pulp therapy.

    Measured: One week after pulpotomy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2026
  2. Study start21 Dec 2025
  3. Primary completionJul 2027 (estimated)
  4. Study completionJul 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
All participants will receive the same stepwise vital pulp therapy protocol. Partial pulpotomy will be performed as the initial treatment approach. If adequate hemostasis cannot be achieved following partial pulpotomy, the procedure will be converted to full pulpotomy. The final treatment provided will therefore depend on the pulpal response during the procedure. Participants will be followed prospectively to evaluate clinical and radiographic outcomes after treatment.
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07756216
Sponsor's protocol ID
547/2025
Status last verified
Aug 2026
First submitted
5 Aug 2026
Last updated
12 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual participant data will not be publicly shared due to institutional regulations regarding data access and participant confidentiality. Requests for access to study data may be considered by the principal investigator following publication of the study results and in accordance with university policies and applicable ethical requirements.

Questions about this trial

What is this clinical trial studying?

A study testing Step wise pulpotomy in people with Molar Hypomineralization, run by King Abdullah University Hospital at 1 site in Jordan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success of pulpotomy (time frame: 6 and 12 months after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in